• Force-Regulated Motor Coordination in TNT-Mediated Organelle

  2026-05-30

  This study uncovers how force-regulated multimotor coordination facilitates bidirectional lipid droplet transport within tunneling nanotubes (TNTs), using a custom optical tweezers-confocal system. The findings provide a quantitative framework for understanding mechanical cargo dynamics in confined intercellular structures, with implications for organelle exchange and cellular communication.

• Vernakalant Hydrochloride: Optimizing Rapid Atrial Fibrillat

  2026-05-29

  Vernakalant Hydrochloride (RSD1235) sets a new standard for atrial fibrillation research, offering multi-ion channel selectivity and rapid, atrial-specific action with minimal ventricular risk. This guide details practical protocols, experimental enhancements, and troubleshooting strategies that leverage APExBIO’s trusted quality for reliable, reproducible AF studies.

• Minocycline HCl in Regenerative Assays: Beyond Antimicrobial

  2026-05-29

  Explore Minocycline HCl as more than a broad-spectrum antibiotic—this in-depth article unveils its role in regenerative assay design, focusing on inflammation, neuroprotection, and cellular signaling, with actionable insights for translational research.

• Erastin and the Tumor Microenvironment: Ferroptosis in NPC R

  2026-05-28

  Explore how Erastin, a leading ferroptosis inducer, uniquely enables breakthroughs in radiosensitization research for nasopharyngeal carcinoma (NPC) by targeting the tumor microenvironment. This cornerstone article integrates mechanistic insights and practical protocols, offering a distinct perspective for advanced cancer biology research.

• Anlotinib Hydrochloride: Strategic Innovation in Anti-Angiog

  2026-05-28

  Explore how Anlotinib hydrochloride, a next-generation multi-target tyrosine kinase inhibitor, is redefining experimental and translational paradigms in angiogenesis and cancer research. This article blends mechanistic insight with strategic guidance, offering actionable protocols and a critical outlook for researchers seeking to accelerate the bench-to-bedside journey.

• ML133 HCl: Elevating Potassium Channel Inhibition in Vascula

  2026-05-27

  Explore the advanced selectivity and scientific utility of ML133 HCl as a potassium channel inhibitor, with a special focus on its distinct role in pulmonary artery smooth muscle cell proliferation research. Gain actionable, evidence-based insights for cardiovascular ion channel studies.

• EZ Cap™ Cy5 EGFP mRNA (5-moUTP): Real-Time Assay Revolution

  2026-05-27

  Discover how EZ Cap™ Cy5 EGFP mRNA (5-moUTP) enables unprecedented real-time, dual-fluorescence tracking of mRNA delivery and translation. This in-depth analysis unveils new assay strategies and practical insights for researchers optimizing gene delivery systems.

• IWP-2: Wnt Production Inhibitor Workflows in Cancer Research

  2026-05-26

  IWP-2, a potent Wnt production inhibitor from APExBIO, enables precise modulation of the Wnt/β-catenin pathway in cancer and regenerative models. This article distills bench-proven workflows, protocol enhancements, and troubleshooting strategies to help researchers achieve reproducible, high-impact results across cancer and cell biology applications.

• Actinomycin D: Applied Workflows for Cancer Research & mRNA

  2026-05-26

  Actinomycin D (ActD) delivers unmatched precision for probing transcriptional regulation, apoptosis induction, and mRNA stability in cancer research. Leverage APExBIO’s validated ActD (A4448) to enhance experimental reproducibility, troubleshoot workflow bottlenecks, and translate lncRNA mechanistic insights into actionable protocols.

• Angiotensin Peptides Enhance SARS-CoV-2 Spike–AXL Interactio

  2026-05-25

  This study uncovers how naturally occurring angiotensin peptides, especially Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) and its truncated forms, increase SARS-CoV-2 spike protein binding to the AXL receptor. The findings reveal a novel molecular link between the renin–angiotensin system and viral entry mechanisms, with implications for COVID-19 pathogenesis and potential therapeutic targeting.

• Oligomycin A: Precision Mitochondrial ATP Synthase Inhibitor

  2026-05-25

  Oligomycin A from APExBIO empowers researchers to dissect mitochondrial bioenergetics and cancer metabolism with unmatched specificity. This article delivers practical protocols, troubleshooting insights, and advanced applications—bridging recent mechanistic discoveries with robust, reproducible bench workflows.

• KSHV miRNAs Suppress STING to Evade Host Immunity and Delay

  2026-05-24

  Paulsen et al. uncover a mechanism by which Kaposi sarcoma-associated herpesvirus (KSHV) miRNAs directly target and repress STING, a key innate immune sensor, to enable immune evasion and facilitate viral reactivation. These findings clarify how viral miRNAs modulate the cGAS/STING pathway, informing strategies for dissecting viral latency and reactivation using gene expression analysis.

• Jiao-tai-wan/Coptisine Mitigate PCOS via SIRT1 Ubiquitinatio

  2026-05-23

  The reference study reveals that the traditional herbal formula Jiao-tai-wan (JTW) and its component coptisine attenuate polycystic ovary syndrome (PCOS) in rat models by suppressing SIRT1 ubiquitination, thereby normalizing mitochondrial cholesterol import and ovarian steroidogenesis. These mechanistic insights highlight a novel molecular target for PCOS intervention and provide a foundation for future translational research.

• Valemetostat (DS-3201): Dual EZH1/EZH2 Inhibition for Transl

  2026-05-22

  This thought-leadership article explores the mechanistic underpinnings, translational strategies, and future potential of Valemetostat (DS-3201) as a dual EZH1/EZH2 inhibitor in lymphoma and beyond. It integrates new evidence on immunogenic reprogramming, offers protocol guidance, and positions APExBIO’s Valemetostat as a critical tool for innovative epigenetic cancer therapy.

• HyperScribe™ T7 High Yield Cy5 RNA Labeling Kit: Protocol &

  2026-05-22

  The HyperScribe™ T7 High Yield Cy5 RNA Labeling Kit enables high-efficiency, random fluorescent RNA probe synthesis using Cy5-UTP during in vitro transcription. Its optimized T7 RNA polymerase mix supports sensitive applications like in situ hybridization and Northern blotting. This article details the kit's mechanism, evidence base, and workflow integration for reproducible RNA probe labeling.

15229 records 1/1016 page Next 12345 下5页 Last page